# Remimazolam Besylate in Sedation of Postcardioperative Patients

> **NCT06716840** · NA · RECRUITING · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 120 (estimated)

## Conditions studied

- Remimazolam
- Propofol
- Sedation
- Mechanical Ventilation
- Intensive Care
- Cardiac Surgery

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT06716840
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-05-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06716840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06716840, "Remimazolam Besylate in Sedation of Postcardioperative Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06716840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*